GE Medical Systems Introduces Hawkeye

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 9 No 7
Volume 9
Issue 7

WAUKESHA, Wisconsin-GE Medical Systems is now marketing its Millennium VG Hawkeye, an imaging system that combines CT anatomic images with PET functional images. At one clinical test site, doctors reported that Hawkeye images influenced treatment in 25% of patients, the company said in a news release.

WAUKESHA, Wisconsin—GE Medical Systems is now marketing its Millennium VG Hawkeye, an imaging system that combines CT anatomic images with PET functional images. At one clinical test site, doctors reported that Hawkeye images influenced treatment in 25% of patients, the company said in a news release.

During more than a year of intensive testing, researchers used Hawkeye to create more than 1,000 clinical images. The first test sites were at Vanderbilt University Medical Center and Rambam Medical Center, Haifa, Israel.

Recent Videos
Taletrectinib showed improved efficacy in patients with ROS1-positive non–small cell lung cancer who were treatment-naïve.
“It’s a drug that I’m very comfortable with, and it is a drug I’ll likely use primarily in the first-line setting,” stated Jorge Nieva, MD, on taletrectinib in non–small cell lung cancer.
4 experts in this video
4 experts in this video
Those being treated for peritoneal carcinomatosis may not have to experience the complication rates or prolonged recovery associated with surgical options.
For patients with peritoneal carcinomatosis, integrating PIPAC into a treatment regimen does not interrupt their systemic therapy.